IRCT20200105046010N86招募中Unknown
Bioequivalence study of ?valsartan/sacobitril 200mg tablet (Elpido) manufactured by Abidi Co versus Entresto 200 mg tablet manufactured by Novartis in fasting condition in Iranian healthy volunteers
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 55 years(—)
- 性别
- All
入选标准
- •General Health (Liver, Heart, and Kidney)
- •Body Mass Index (18-28)
- •Informed consent
- •Age (18-55 years old)
排除标准
- •History of cardiovascular disease
- •History of liver and kidney disease
- •Alcoholism and Narcoticism
- •History of allergy to valsartan and sacobitril
研究者
相似试验
招募中
Unknown
Bioequivalence study of Sacubitril/valsartan 200mg tabletThis study is performed on healthy volunteers and drug concentration in plasma is determined..IRCT20200623047902N41Actover company37
尚未招募
不适用
Bioequivalence study of Valsartan 160 mg tablet in 24 healthy male under fasting conditionsBioequivalence investigation of the generic Karen Pharma and Food Supplement Co. Valsartan 160 mg tablet with brand Diovan® 160 mg tablet Novartis pharmaceuticals...IRCT20180620040164N18Karen Pharma and Food Supplement Co.24
已完成
不适用
Bioequivalence study of Valsartan 160 mgHealthy volunteers.IRCT20200623047902N5Sanamed pharma company24
招募中
2 期
Investigating the effect of valsartan sacubitril on left ventricular functioIRCT20240117060713N1Ahvaz University of Medical Sciences92
尚未招募
不适用
Bioeqivalence study of amlodipine valsartan 10/160 mg tabletBioequivalence study.IRCT20220209053979N5Alborz Darou24
